A new study, led by researchers from Saint Antoine Hospital, in France, reveals that ileal mucosa-associated microbiota may help predict recurrence in patients with CD after ileocecal resection .
Recurrence of inflammatory lesions is frequent in patients undergoing ileal resection for Crohn’s disease (CD), although there is not a single clinical risk factor that can be used as a perfect predictor of early postoperative endoscopic recurrence. The researchers of this study sought a microbiotic biomarker to predict recurrence. To this end they catalogued the ileal mucosa-associated microbiota by using ribosomal 16S sequencing at the time of surgery and/or at the time of postoperative endoscopic evaluation (about 6 to 12 months after surgery) in 201 patients from 9 centres in the prospective REMIND cohort. Not surprisingly, antibiotics treatment within one month before surgery had a dramatic impa...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Early stages of gastric metaplasia: molecular profiling Next Article
Ustekinumab is safe and effective in ulcerative colitis: 2-year data »
Table of Contents: UEGW 2019
Upper GI Disorders
Irritable Bowel Syndrome
Inflammatory Bowel Diseases
Microbiome and Microbiota
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.